News about us

  • The Danish Medicines Agency will be closed on Friday 10 June 2022

    | 08 June 2022 |

    The Danish Medicines Agency will be holding its staff convention and will be closed on  Friday 10 June 2022 However, we process urgent applications for compassionate use permits (applications for d

  • New executive order raises fees in the area of the Danish Medicines Agency

    | 03 May 2022 |

    Higher fees become payable for medicinal products and pharmaceutical companies as a result of a new executive order entering into force on 1 May 2022. The last time the fees were adjusted was in 2017.

  • Danish Medicines Agency presents new strategy

    | 05 April 2022 |

    Lars Bo Nielsen, Director General of the Danish Medicines Agency, announces new 2022-26 strategy for the agency. The strategy supports the Danish Ministry of Health’s joint corporate strategy and emphasises a vision to lead national and international collaboration, for example regarding better use of data and new technology and dialogue with public and society in general.

  • The uploading of package leaflets via DKMAnet is closed in the period from September 10 to September 14

    | 09 September 2021 |

    As previously announced, there have been errors in the display of company names and marketing authorisation status for certain medicines on www.indlaegsseddel.dk . The Danish Medicines Agency is no

  • Error in company names and marketing status at www.indlaegsseddel.dk

    | 10 August 2021 |

    The Danish Medicines Agency is aware that an incorrect company name and marketing status are shown for some medicines at www.indlaegsseddel.dk.

  • Dean of Aarhus University to join the Danish Medicines Agency as new Director General

    | 26 May 2021 |

    The Ministry of Health has appointed Lars Bo Nielsen, Dean at Aarhus University, as Director General of the Danish Medicines Agency. Lars Bo Nielsen is a qualified doctor and has extensive leadership experience within both the health and science areas.

  • Becoming part of Europe’s best in class

    | 03 June 2020 |

    The foundation of the Data Analytics Center was established, our European position was strengthened, yet not all objectives were achieved. This is the conclusion in the Danish Medicines Agency’s annual report for 2019.

  • Danish Medicines Agency to help build better drug regulatory authorities in low- and middle-income countries

    | 14 March 2019 |

    Today, the Danish Medicines Agency signed an agreement with WHO to help build up drug regulatory authorities in low- and middle-income countries, including Africa.

  • New data analysis centre to open at the Danish Medicines Agency

    | 08 February 2019 |

    The Danish government today announced its decision to support the establishment of a new data analysis centre in the Danish Medicines Agency. The centre is to handle the analysis of large data quantities in the pharmaceutical and medical devices areas and will set new standards for the monitoring of the safety and efficacy of medicines and medical devices after their marketing.

  • Danish Medicines Agency aces European benchmark survey

    | 19 September 2018 |

    The Danish Medicines Agency has just scored 4.5 of a possible 5 in the common-European survey known as the Benchmarking of European Medicines Agencies (BEMA). ”It's a really good result that will benefit all of us and may help raise the standard throughout Europe,” said the Danish health minister.

  • Danish Medicines Agency lands new European chairmanship

    | 20 August 2018 |

    Nikolai Brun, Director of Medical Evaluation & Biostatistics, has been elected chair of the Task Force on Big Data in the pharmaceutical area. The task force is a collaboration between the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) which is to identify advantages and challenges of using big data for the development of medicine.

  • Danish-Japanese collaboration on better use of health data

    | 02 May 2018 |

    The Danish Medicines Agency met today with leading representatives from the Japanese Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices Agency at the Danish Medicines Agency in Copenhagen. The purpose of the meeting was to exchange knowledge and experience regarding regulatory work in the pharmaceutical area, and to begin a broader collaboration between the agencies.

  • European top post for Thomas Senderovitz

    | 02 March 2018 |

    Director General of the Danish Medicines Agency, Thomas Senderovitz, was Thursday elected Chairperson of the HMA Management Group. HMA is an acronym for Heads of Medicines Agencies and is the network of the heads of the national drug regulatory authorities in Europe.

  • EMA to relocate to Amsterdam

    | 21 November 2017 |

    he Danish Medicines Agency congratulates Amsterdam on winning the hosting of the EMA and looks forward to a good and constructive cooperation.

  • New Director of Division for Pharmacovigilance & Medical Devices

    | 03 November 2017 |

    Jens Piero Quartarolo has been appointed new Director of Division for Pharmacovigilance & Medical Devices and will form part of the Danish Medicines Agency's leadership team.

  • Keep up with the latest updates on our website

    | 27 October 2017 |

    Now you can keep up with all updates on the Danish Medicines Agency's website and not only our news items. You can filter the overview by category and month, and the overview is structured in chronological order with the latest update first. You can find a shortcut to the overview on our home page.

  • The Danish Medicines Agency contributes to review of Chinese medicines act

    | 10 October 2017 |

    On Monday 9 October, a Chinese delegation headed by Xu Jinghe visited the Danish Medicines Agency. Xu Jinghe is Director General of the CFDA's Department of Legal Affairs and one of the main architects of the renewal of the Chinese medicines legislation.

  • Substantial progress in cooperation with CFDA only six weeks after state visit

    | 23 June 2017 |

    During the official state visit at the beginning of May, the Chinese and Danish Ministers for Health and Food signed a Memorandum of Understanding about the establishment of the China-Denmark Food and Drug Regulatory Cooperation Centre. Only six weeks after the state visit, the China Food and Drug Administration (CFDA) and the Danish Medicines Agency held a successful seminar on 20 and 21 June in Beijing on the licensing of medicines and the drafting of a work programme with common activities up to and including 2020.

  • Extensive modernisation of our IT from 8 June to 13 June

    | 08 June 2017 |

    The Danish Medicines Agency will launch an extensive modernisation of our IT systems from Thursday 8 June 2017 at 6pm to Tuesday 13 June 2017 at 8am. During this period, you may experience longer response times and some of our IT systems and forms will not be available.

  • Agreement on Chinese-Danish cooperation signed

    | 03 May 2017 |

    The Danish Medicines Agency and the China Food and Drug Administration have taken an important step towards closer cooperation.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.


...